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Abstract
Background: Impaired vascular function occurs early in atherogenesis. Brachial flow mediated
dilatation (FMD) is a non-invasive measure of vascular function and may be an important marker of
preclinical atherosclerosis. Data on the association between FMD and carotid plaque in multi-
ethnic populations are limited. The objective of this study was to determine whether endothelial
dysfunction is independently associated with carotid plaque in a community of northern Manhattan.
Methods: In the population-based Northern Manhattan Study (NOMAS), high-resolution B-mode
ultrasound images of the brachial and carotid arteries were obtained in 643 stroke-free subjects
(mean age 66 years; 55% women; 65% Caribbean-Hispanic, 17% African-American, 16% Caucasian).
Brachial FMD was measured during reactive hyperemia. Maximum carotid plaque thickness (MCPT)
was measured at the peak plaque prominence.
Results: The mean brachial FMD was 5.78 ± 3.83 %. Carotid plaque was present in 339 (53%)
subjects. The mean MCPT was 1.68 ± 0.82 mm, and the 75th percentile was 2.0 mm. Reduced FMD
was significantly associated with increased MCPT. After adjusting for demographics, vascular risk
factors, and education, each percent of FMD decrease was associated with a significant 0.02 mm
increase in MCPT (p = 0.028). In a dichotomous adjusted model, blunted FMD was associated with
an increased risk of MCPT ≥ 2.0 mm (OR, 1.11 for every 1% decrease in FMD; 95% CI, 1.03–1.19).
Conclusion: Decreased brachial FMD is independently associated with carotid plaque. Non-
invasive evaluation of endothelial dysfunction may be a useful marker of preclinical atherosclerosis
and help to individualize cardiovascular risk assessment beyond traditional risk factors.
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Background
Atherosclerosis is characterized by a low-grade systemic
inflammatory response and endothelial dysfunction [1].
Endothelial dysfunction is comprised of increased expres-
sion of cellular adhesion molecules, loss of anticoagulant
properties, and increased vascular tone due to loss of bio-
availability of vasodilatory endothelial nitric oxide [2].
Flow-mediated dilatation (FMD) of the brachial artery is
a reliable and reproducible non-invasive tool used to eval-
uate endothelial function [3]. Impaired brachial FMD has
been associated with traditional cardiovascular risk fac-
tors and has been observed to predict cardiovascular
events in selected high-risk groups of patients [4,6].
Carotid plaque and intima-media thickness (IMT)
detected by non-invasive high-resolution ultrasound are
markers of systemic subclinical atherosclerosis and strong
predictors of future myocardial infarction (MI) and stroke
[7,9]. Several case-control studies have observed an asso-
ciation between decreased brachial FMD and increased
IMT, thus linking endothelial dysfunction to atherogene-
sis [10]. However, these studies were limited by their
small sample size and by issues in study design. Recently,
no significant correlation between brachial FMD and
carotid IMT was observed among middle-aged healthy
men [11]. In the same population, FMD was not associ-
ated with traditional vascular risk factors; while the oppo-
site was reported in individuals at low cardiovascular risk
in a recent meta-analysis [12] as well as in other cohorts
[13]. There is an ongoing debate whether FMD is associ-
ated with other imaging markers of systemic subclinical
atherosclerosis and to which extent is modified by the
effects of vascular risk factors. Carotid plaque may be a
distinctive phenotype of atherosclerosis and not a contin-
uum of increased wall thickness or IMT progression
[10,14]. In this study, we sought to examine the associa-
tion between endothelial function and carotid plaque in
an urban population-based multiethnic cohort, and to
investigate possible interactions with age, race-ethnicity,
and traditional vascular risk factors.
Methods
Study population
The study population was obtained from the Northern
Manhattan Study (NOMAS), an ongoing community-
based study designed to investigate vascular risk factors
and the incidence of vascular events, to identify novel risk
factors, and to provide data on the association of various
vascular risk factors and subclinical atherosclerosis in dif-
ferent race-ethnic groups in northern Manhattan [15,16].
NOMAS is comprised of 3,298 adult subjects without
prior MI or stroke. After several months of piloting bra-
chial FMD in our cohort and working out the technical
methods, we began collecting data on FMD in 1998. Par-
ticipants who were undergoing cardiac echo were selected
to undergo brachial FMD testing. Between January 1998
and April 2001, we obtained high quality FMD images
among 842 subjects of whom 643 had both carotid ultra-
sonography and brachial FMD measurements performed.
These subjects were not significantly different from the
parent cohort with respect to demographic and risk fac-
tors. The cardiovascular risk factors were collected using
the CDC Risk Factor Surveillance Instrument. Hyperten-
sion was defined as a systolic blood pressure ≥ 140 mmHg
or a diastolic blood pressure ≥ 90 mmHg, or the patient's
self-report of a history of hypertension or antihyperten-
sive medication use. Diabetes mellitus was defined as
either a fasting blood glucose level ≥ 126 mg/dL or the
subject's self-report of diabetes, insulin use, or oral
hypoglycemic use. Hypercholesterolemia was defined as a
history of elevated cholesterol, taking medications for ele-
vated cholesterol or a total cholesterol level > 240. Current
tobacco use was defined as smoking within the past year.
Alcohol use was defined as more than one drink per
month. Physical activity was categorized as any, if any par-
ticipation in usual leisure physical activities was reported,
or none. The study was approved by the Columbia Uni-
versity Medical Center Institutional Review Board, and all
patients gave written informed consent.
Assessment of endothelial function
Endothelial function was assessed by measuring brachial
artery FMD in response to reactive hyperemia using high-
resolution B-mode ultrasound [3]. Participants fasted for
12 hours prior to the brachial FMD examination. They
were asked not to ingest substances that might affect flow
mediated dilatation (FMD) such as caffeine, or use
tobacco at least 6 hours prior to the appointment, and to
avoid vasoactive medications for 24 hours prior to the
study. The brachial artery diameter was measured 6 cm
proximal to the antecubital crease using a 7–15 MHz lin-
ear array transducer (Philips 5500, Andover, MA). Flow-
mediated dilatation was measured as the response to reac-
tive hyperemia induced by a 5-minute blood pressure cuff
occlusion of the upper arm. Inflation pressure was 200
mmHg if the subject's pre-examination systolic blood
pressure was less than 150 mmHg, or 50 mmHg above the
systolic blood pressure if it was greater than 150 mmHg
but less than 180 mmHg. End-diastolic images were
acquired at baseline and 1 minute after cuff deflation.
Data was analyzed using CVI analysis and acquisition
software (Data Translation, MA). Flow-mediated dilata-
tion was expressed as FMD = [(brachial artery diameter at
peak hyperemia - diameter at rest)/diameter at rest × 100].
Intra-observer and inter-observer variability for FMD
measurements were 1.3% and 2.7%, respectively (n = 15).
Assessment of carotid plaque
Carotid artery plaque was assessed according to a standard
scanning and reading protocols [17] using high-resolu-BMC Cardiovascular Disorders 2006, 6:35 http://www.biomedcentral.com/1471-2261/6/35
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tion B-mode ultrasound GE LOGIQ 700 system with a
multifrequency 9–13 MHz linear-array transducer. The
internal carotid and common carotid arteries as well as
the bifurcations were examined for the presence of athero-
sclerotic plaque, defined as an area of focal wall thicken-
ing or protrusion into the lumen at least 50% greater than
surrounding total wall thickness. Maximum carotid
plaque thickness (MCPT) was measured at the peak
plaque prominence from any of the three carotid artery
segments using a semi-automatic IMAGE-Pro V.5.2 soft-
ware (Microsoft). If plaque was not identified, plaque
thickness was recorded as zero. The intraclass correlation
coefficients for within and between reader variability of
MCPT measurements were 0.94 and 0.77, respectively (n
= 88) [18].
Statistical analysis
All statistical analyses were performed using SAS 8.2 (SAS
Institute, Cary, NC). All continuous data are presented as
a mean value ± SD, and all categorical data are reported as
a percentage or absolute number. Student's t tests and
Chi-square tests were used to assess differences between
groups. The association between FMD and MCPT was
analyzed by multivariable linear and logistic regression
analyses. The dependent variable, MCPT, was analyzed as
a continuous variable, and dichotomized using the 75th
percentile cut off level of the plaque thickness distribu-
tion. These analyses were adjusted for demographics,
hypertension, hypercholesterolemia, diabetes, education,
physical activity, alcohol, and current smoking. The
results are reported as slopes (β) for the linear regression
models and as odds ratios (OR) for the logistic regression.
To test for differences in the effect of FMD on MCPT
among age and race-ethnic groups, interaction terms were
added to the multivariate models.
Results
Study population
The study population included 643 subjects with a mean
age of 66.1 ± 8.5 years (range, 54–94 years), 55% female,
65% Hispanic, 17% African American, and 16% Cauca-
sian (Table 1). The prevalence of risk factors was as fol-
lows: 67% hypertension, 24% diabetes, 50%
hypercholesterolemia, 43% subjects reported consuming
more than one glass of alcohol per month, 13% were cur-
rent smokers, 49% were physically inactive, and 41%
completed high school. The mean brachial artery diame-
ter at baseline was 3.9 ± 0.7 mm, and the mean absolute
change was 0.22 ± 0.14 mm, with a mean percent change
in diameter (FMD) of 5.78 ± 3.83. Significant correlation
was found between FMD and baseline brachial artery
diameter (r = -.414, p<0.001) was found. Carotid plaque
was present in 339 subjects (53%). The mean MCPT was
1.68 ± 0.82 mm (range 0 – 8.0 mm). The 75th percentile
of the MCPT distribution was 2.0 mm.
Relationship between brachial FMD and carotid plaque 
(MCPT)
Mean FMD was lower among subjects with carotid plaque
(5.42 ± 3.86) than among subjects without plaque (6.18
± 3.75), p = 0.01 (Figure 1). Subjects in the lowest quartile
of FMD (<2.81) were more likely to have MCPT ≥ 2.0 mm,
Table 1: Characteristics of study subjects from the Northern Manhattan Study
N Prevalence (%) or Mean ± SD
Total 643 --
Age 643 66.1 ± 8.5 years
Men 290 45 %
Hispanic 417 65 %
African American 109 17 %
Caucasian 102 16 %
Hypertension 431 67 %
Diabetes mellitus 154 24 %
Hypercholesterolemia 322 50 %
Alcohol consumption 276 43 %
Current smoking 84 13 %
Physical inactivity 315 49 %
Completed high school 264 41 %
Carotid plaque 339 53%
MCPT (mm) 643 1.68 ± 0.82
75th percentile 2.00
Baseline diameter of the brachial artery (mm) 643 3.90 ± 0.71
FMD (%) 643 5.78 ± 3.83
FMD = flow mediated dilatation, MCPT= maximum carotid plaque thicknessBMC Cardiovascular Disorders 2006, 6:35 http://www.biomedcentral.com/1471-2261/6/35
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with 22% of them compared to 9% in subjects in the high-
est quartile of FMD (≥ 8.38), p<0.01 (data not shown).
Reduced FMD was significantly associated with increased
MCPT in a univariate regression model (β = -0.038,
p<0.001). After adjusting for demographics and risk fac-
tors, and baseline diameter of the brachial artery the mag-
nitude of the effect was reduced but FMD remained
significantly associated with increased MCPT (Table 2, β =
-0.021, p = 0.027). No significant interactions between
FMD and hypertension, diabetes, or smoking were found.
In a dichotomous model, lower FMD was significantly
associated with MCPT ≥ 2.0 mm (OR, 1.10 for every 1%
decrease in FMD; 95% CI, 1.04–1.18) in a univariate and
in a multivariate model (Table 3).
Interactions with age, sex, and race-ethnicity
No significant differences were detected in the effect of
FMD on MCPT among various race-ethnic groups in
either the univariate (p = 0.37) or multivariable (p = 0.27)
logistic regression models although the OR for Caucasians
(1.23; 95% CI, 0.97–1.49) showed a somewhat larger
effect than for African Americans (1.04; 95% CI, 0.89–
1.20) or Caribbean Hispanics (1.06; 95% CI, 0.97–1.16).
The differences were found for the FMD effect among
those aged 65 or older (adjusted OR = 1.16; 95% CI,
1.03–1.49), than in those younger than 65 years (adjusted
OR = 1.01; 95% CI, 0.90–1.14), although not statistically
significant (p = 0.06). No significant difference in the
association of FMD with MCPT was found between men
and women.
Discussion
We found a significant association between endothelial
dysfunction and presence of carotid plaque in a popula-
tion-based cohort. Impairment of brachial FMD was more
pronounced among those with carotid plaques thicker
than 2 mm. This thickness was associated with a high car-
diovascular risk [7,9]. The inverse relationship between
FMD and carotid plaque was independent of demograph-
ics and traditional vascular risk factors, raising the possi-
bility that endothelial dysfunction may directly promote
atherogenesis. Our observation emphasizes the impor-
tance of evaluating endothelial function in the assessment
of vascular risk beyond traditional risk factors. Further-
more, carotid artery plaque assessment in the combina-
tion with FMD may be a useful monitoring tool for high
risk individuals.
Other investigators have assessed the relationship
between FMD and subclinical atherosclerosis. AA mong
2,109 young healthy adults from the Young Finns study
(ages 24 to 39), brachial FMD was inversely and signifi-
cantly associated with carotid IMT [19]. In contrast, no
significant correlation between brachial FMD and carotid
IMT was observed among 1,578 middle-aged healthy men
from the Firefighters and their Endothelium (FATE) study
[11]. Although the FATE study population consisted of
only men who were slightly older than the Young Finns
population (mean age of 49 ± 10 years), the discrepancy
in the results from these two population is striking. A dif-
ferent IMT measurement technique is the most evident
dissimilarity. In the Young Finns study, IMT was meas-
ured only from the far wall of the distal part of the com-
mon carotid artery; while a more complex carotid IMT
score including the internal and common carotid arteries
and bifurcation was used in the FATE study. The results
from the FATE study are somehow contraintuitive as a
more complex and presumably more detailed analysis of
IMT was less likely to show a significant relationship with
FMD. Furthermore, even if one assumes differences in
IMT measurement techniques to be responsible for these
discrepant results, it cannot explain almost total lack of
association between FMD and conventional cardiovascu-
lar risk factors in the FATE study. Other characteristics of
the study populations may also have accounted for the
Table 2: Association between brachial FMD and maximum 
carotid artery thickness (MCPT)
β p
FMD -0.021 0.027
Age (per year) 0.041 <0.001
Current Smoking 0.378 0.001
Male 0.073 0.366
Systolic Blood Pressure (per mm Hg) 0.001 0.566
Diabetes 0.098 0.292
High Cholesterol 0.140 0.060
Completed high school 0.069 0.363
Physical Activity 0.038 0.650
Alcohol Consumption -0.019 0.899
Baseline diameter of the brachial artery (mm) 0.193 0.072
The mean ( ± SD) values of brachial FMD among 304 (47%)  subjects without carotid plaque and among 339 (53%) sub- jects with carotid plaque Figure 1
The mean ( ± SD) values of brachial FMD among 304 (47%) 
subjects without carotid plaque and among 339 (53%) sub-
jects with carotid plaque.
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conflicting results. None of the studies reported on the
presence of carotid plaque.
In our study, carotid plaque thickness, not carotid IMT,
was used as a measure of subclinical atherosclerosis, and
was significantly associated with reduced FMD. Carotid
plaque may be a distinctive phenotype of atherosclerosis
and not just a continuum of increased wall thickness or
IMT progression. Carotid IMT, especially in early develop-
ment, represents mainly hypertensive hypertrophy of the
media and is under substantial genetic control [13]. A
considerable heritability of carotid IMT of 40% was
recently reported [20]; while the heritability of carotid
plaque was insignificant. Indeed, carotid plaque is
strongly influenced by the environmental factors includ-
ing a control of lipids, monocytes, smooth muscle cells,
and oxidative stress. Therefore, endothelial dysfunction
may be more likely associated with plaque due to environ-
mental exposures and less likely associated to IMT which
is under significant genetic control. Several studies have
provided evidence that carotid plaque predicts prevalent
CAD better than does IMT [14,21]. FMD and carotid
plaque may also be independent predictors of vascular
outcome [22]. Reduced availability of endothelium-
derived nitric oxide, as reflected by reduced FMD, may
modulate the impact of atherosclerotic plaque by enhanc-
ing its progression and rapidly increasing the risk for vas-
cular events [23]. Thus, the functional and structural
assessments of the arterial wall may be fundamental
determinants in the prognosis of vascular disease. None-
theless, relatively small and limited case-control studies
and case series have examined the association between
FMD and carotid plaque [10].
The strength of association between FMD and carotid
plaque in our study was similar among men and women,
and various race-ethnic groups. Although preliminary
data suggest that FMD differs by sex and race-ethnicity and
that these differences may parallel differential cardiovas-
cular risk [24], it remains to be determined whether sex
and racial differences in endothelial function explain the
difference in CVD morbidity and mortality. In our cohort,
the association between FMD and carotid plaque was
more pronounced among subjects older than 65 years. It
has already been recognized that many structural and vas-
cular changes occur with aging even among subjects with-
out overt CVD [25].
Numerous studies have reported on the associations
between FMD and vascular risk factors. We have previ-
ously observed the associations of FMD with diabetes and
hypertension [13]. However, we did not find any interac-
tions between FMD and traditional risk factors on the risk
of carotid plaque. In contrast, in the recent meta-analysis,
FMD was related to the risk factors only in the low risk
populations [12]. This discrepancy can be explained by
the different demographics of the studied populations. In
addition the biology of endothelium where its dysfunc-
tion is an initial step in atherogenesis after which an addi-
tion of risk factors may not cause a further decline of
endothelial function. In meta-analysis however, other
confounders including variations between and within the
reported studies may have influenced the results. Smoking
may be an important confounder modifying endothelial
dysfunction [26]. We did not observe a significant interac-
tion between smoking and FMD. Our observation con-
tributes to the hypothesis that endothelial dysfunction
may directly lead to atherogenesis, although some resid-
ual confounding cannot be entirely excluded. The mecha-
nism by which endothelial dysfunction may promote
plaque formation independently of other risk factors is
not clear. Imbalance in the production and degradation of
nitric oxide within the arterial wall may play a major role
by directly influencing atherogenesis through leukocyte
adhesion, lipid deposition, vascular smooth muscle cell
growth, and thrombosis [2].
Strengths of our study include the population-based
design, the diverse ethnic population, and ongoing fol-
low-up, which will allow for the prospective evaluation of
Table 3: Association between brachial FMD and MCPT ≥ 2.0 mm
Odds Ratio 95% Confidence Interval
FMD (per 1% decrease) 1.10 1.04 – 1.18
Age (per year) 1.11 1.08 – 1.11
Current Smoking 2.30 1.28 – 4.44
Male 1.11 0.69 – 1.92
Systolic Blood Pressure (per mmHg) 0.99 0.97 – 1.01
Diabetes 1.39 0.85 – 2.66
High Cholesterol 1.44 0.87 – 2.41
Completed high school 1.04 0.62 – 1.69
Physical Activity 0.88 0.57 – 1.41
Alcohol Consumption 1.05 0.67 – 1.77
Baseline diameter of the brachial artery (mm) 0.87 0.71 – 1.84BMC Cardiovascular Disorders 2006, 6:35 http://www.biomedcentral.com/1471-2261/6/35
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FMD as a clinically useful measure of vascular risk. Our
study also has several limitations. For any such study, tem-
perature, foods, medications, and sympathetic stimuli
may all affect FMD. Attempts were made to control these
factors to the greatest extent possible during subject prep-
aration, yet these factors depend on patient cooperation,
and any aberration may have influenced FMD results.
Measurements of carotid IMT were not available in this
group of subjects therefore the associations between FMD
and IMT were not assessed. However, carotid plaque is an
accepted surrogate marker of atherosclerosis and may be
even a stronger predictor of vascular events than IMT [14].
The reported associations are cross-sectional, not allowing
for determination of whether FMD changes precede
plaque formation.
Conclusion
Endothelial dysfunction in this multi-ethnic population
of older men and women is associated with carotid
plaque. Carotid plaque is a recognized measure of sub-
clinical atherosclerosis and a marker of future cardiovas-
cular events. Impaired FMD predicts vascular events in
selected high-risk groups of patients, and several large
ongoing population-based studies, including MESA [27],
CHS [7], the Framingham Heart Study [4], and NOMAS
[16] will determine whether brachial FMD independently
identifies individuals at risk for developing cardiovascular
disease in the general population.
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